Resmed (RSMDF) Non-Current Deferred Tax Liability (2010 - 2026)

Resmed has reported Non-Current Deferred Tax Liability for 17 years, with the latest figure at $77.9 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 1.33% year-over-year to $77.9 million; the trailing twelve-month figure through Mar 2026 stood at $77.9 million (down 1.33% YoY), and the FY2025 full-year result was $77.7 million, down 2.09% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $77.9 million, roughly flat from $78.0 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $113.0 million in Q1 2023, with the low at $9.7 million in Q2 2022.
• Historically, Non-Current Deferred Tax Liability has averaged $72.8 million across 5 years, with a median of $79.0 million in 2025.
• Annual changes were most pronounced in 2023 — Non-Current Deferred Tax Liability jumped 955.13% — and 2024, when it dropped 23.4%.
• Resmed's Non-Current Deferred Tax Liability stood at $107.5 million in 2022, then declined by 16.98% to $89.3 million in 2023, then declined by 13.75% to $77.0 million in 2024, then rose by 1.29% to $78.0 million in 2025, then slipped by 0.08% to $77.9 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $77.9 million (Q1 2026), $78.0 million (Q4 2025), and $77.6 million (Q3 2025), per Business Quant data.